🇺🇸 FDA
Patent

US 12364765

Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria

granted A61KA61K38/51A61K47/02

Quick answer

US patent 12364765 (Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/51, A61K47/02, A61K47/26, A61K47/60